Home/Filings/4/0001765581-23-000048
4//SEC Filing

Iannone Robert 4

Accession 0001765581-23-000048

CIK 0001232524other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 7:16 PM ET

Size

4.9 KB

Accession

0001765581-23-000048

Insider Transaction Report

Form 4
Period: 2023-06-05
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2023-06-05$129.73/sh1,311$170,07645,315 total
Footnotes (2)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
  • [F2]Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001737329

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:16 PM ET
Size
4.9 KB